sales@businessmarketinsights.com     UK: +442081254005
   

North America Atrial Fibrillation Market to 2027 - Regional Analysis and Forecasts by Treatment Type (Non-pharmacological, Pharmacological); End User (Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories),  and Country

Code: TIPRE00009243 | Pages: 166 | Industry: Pharmaceuticals | Date: Feb 2020
Covid

The North America Atrial Fibrillation market is expected to reach US$ 6,284.87 Mn by 2027 from US$ 2,285.69 Mn in 2019. The market is estimated to grow at a CAGR of 13.7% from 2020 to 2027.

 

The rise of the Atrial Fibrillation market is driven by factors such as the rising number of patients suffering with cardiovascular diseases and rising awareness towards cardiovascular disease. Restraining factor such as high cost of atrial fibrillation devices and procedures is likely to have negative impact on the growth of the market in the coming years.

 

Atrial fibrillation is among the most commonly occurring heart condition, which causes irregular and often abnormally fast heart rates, which can lead to the possibility of a stroke. A large number of populations across the globe are unaware of the symptoms associated with atrial fibrillation and hence remain untreated. For instance, Health Innovation Manchester in November 2018 raised awareness regarding Atrial Fibrillation and other innovative technologies to increase the detection of the disease as part of the Global AF Aware Week.

 

Other than bodies such as associations and organizations, companies in the market have also played an instrumental role in increasing the awareness regarding atrial fibrillation. For instance, Biosense Webster, a Division of Johnson & Johnson, launched two major initiatives as a part of the Global AF Aware Week, which falls between 18–24 November. As a part of the action named Get Smart About AFIB (GSAAF), the company entered into a strategic partnership with the Arrhythmia Alliance to increase knowledge of AF across the healthcare community and the general public. As awareness helps in improving the medical care needed for the treatment of atrial fibrillation, the market is expected to witness considerable growth during the forecast period

 

US is expected to dominate the market in the North America region, owing to the growing geriatric population and rising number of innovations in healthcare. Hence, considering the mentioned factors, the atrial fibrillation market is expected to grow at a significant pace in the US during the forecast period.


US Atrial Fibrillation Market Revenue and Forecasts to 2027 (US$ Mn)

US Atrial Fibrillation Market

 

North America Atrial Fibrillation - MARKET SEGMENTATION

 

North America Atrial Fibrillation Market - By Treatment

  • Non – pharmacological
  • MAZE Surgery
  • Catheter Ablation
  • Electric Cardioversion
  • Pharmacological
  • Anti-arrhythmic Drugs
  • Anti-coagulant Drugs


North America Atrial Fibrillation Market - By End User

  • Hospitals
  • Ambulatory Surgical Centers,
  • Cardiac Catheterization Laboratories

 

North America Atrial Fibrillation Market - By Geography

  • North America
    • US
    • Canada
    • Mexico

 

Company Profiles

  • Boston Scientific Corporation
  • Medtronic
  • AtriCure, Inc
  • BOEHRINGER INGELHEIM GMBH, Inc
  • CardioFocus
  • Abbott
  • Sanofi
  • Bristol-Myers Squibb Company
  • Biotronik, Inc
  • Biosense Webster, Inc.

 

1.           Introduction

1.1         Scope of The Study

1.2         The Insight Partners Research Report Guidance

2.           North America Atrial Fibrillation for Healthcare Market– Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Atrial Fibrillation Market – Market Landscape

4.1         Overview

4.2         Market Segmentation

4.2.1        North America Atrial Fibrillation Market – By Treatment Type

4.2.2        North America Atrial Fibrillation Market – By End User

4.2.3        North America Atrial Fibrillation Market – By Geography

4.3         Pest Analysis

4.3.1        North America – PEST Analysis

5.           North America Atrial Fibrillation Market- Key Market Dynamics

5.1         Key Market Drivers

5.1.1        Rising Number of Patients Suffering with Cardiovascular Diseases

5.2         Restraints

5.2.1        High Cost of Atrial Fibrillation Devices and Procedures

5.3         Key Market Opportunities

5.3.1        Growth Opportunities in The Developing Nations

5.4         Future Trends

5.4.1        Development of Novel Technologies

5.5         Impact Analysis

6.           Atrial Fibrillation Market – North America Analysis

6.1         North America Atrial Fibrillation Market Revenue Forecasts and Analysis

6.2         Market Positioning

6.3         Performance of Key Players

6.3.1        Biosense Webster, Inc. (Johnson & Johnson)

6.3.2        Medtronic

7.           North America Atrial Fibrillation Market Analysis – By Treatment Type

7.1         Overview

7.2         North America Atrial Fibrillation Market, By Treatment Type, 2018 & 2027 (%)

7.3         North America Atrial Fibrillation Market Revenue and Forecasts to 2027, By Product Type (Us$ Mn)

7.4         Non-Pharmacological

7.4.1        Overview

7.5         Non-Pharmacological Atrial Fibrillation Market Revenue and Forecast to 2027 (US$ Mn)

7.5.1        MAZE Surgery

7.5.1.1          Overview

7.5.1.2          MAZE Surgery Market Revenue and Forecast to 2027 (US$ Mn)

7.5.2        Catheter Ablation

7.5.2.1          Overview

7.5.2.2          Catheter Ablation Market Revenue and Forecast to 2027 (US$ Mn)

7.5.3        Electric Cardioversion Market

7.5.3.1          Overview

7.5.3.2          Electric Cardioversion Market Revenue and Forecast to 2027 (US$ Mn)

7.6         Pharmacological

7.6.1        Overview

7.6.2        Pharmacological Market Revenue and Forecast to 2027 (US$ Mn)

7.6.3        Anti-Arrhythmic Drugs Market

7.6.3.1          Overview

7.6.3.2          Anti-Arrhythmic Drugs Market Revenue and Forecast to 2027 (US$ Mn)

7.6.4        Anti-Coagulant Drugs Market

7.6.4.1          Overview

7.6.4.2          Anti-Coagulant Drugs Market Revenue and Forecast to 2027 (US$ Mn)

8.           North America Atrial Fibrillation Market Analysis – By End User

8.1         Overview

8.2         North America Atrial Fibrillation Market, By End User, 2018 & 2027 (%)

8.3         North America Atrial Fibrillation Market Revenue And Forecasts To 2027, By End User (Us$ Mn)

8.4         Hospitals

8.4.1        Overview

8.4.2        North America Hospitals Market Revenue and Forecast to 2027 (US$ Mn)

8.5         Ambulatory Surgical Centres

8.5.1        Overview

8.5.2        Ambulatory Surgery Centres Market Revenue and Forecast to 2027 (US$ Mn)

8.6         Cardiac Catheterization Laboratories

8.6.1        Overview

8.6.2        North America Cardiac Catheterization Laboratories Market Revenue and Forecast to 2027 (US$ Mn)

8.7         North America Atrial Fibrillation market

8.7.1        Overview

8.7.2        North America Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)

8.7.3        North America Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type (US$ Mn)

8.7.3.1          North America Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)

8.7.3.2          North America Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)

8.7.4        North America Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)

8.7.5        North America Atrial Fibrillation Market, Revenue and Forecast to 2027, by Country (%)

8.7.6        United States

8.7.6.1          US Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)

8.7.6.2          US Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)

8.7.6.2.1          US Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)

8.7.6.2.2          US Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)

8.7.6.3          US Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)

8.7.7        Canada

8.7.7.1          Canada Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)

8.7.7.2          Canada Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)

8.7.7.2.1          Canada Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)

8.7.7.2.2          Canada Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)

8.7.7.3          Canada Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)

8.7.8        Mexico

8.7.8.1          Mexico Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)

8.7.8.2          Mexico Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)

8.7.8.2.1          Mexico Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)

8.7.8.2.2          Mexico Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)

8.7.8.3          Mexico Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)

9.           Atrial Fibrillation Market –Industry Landscape

9.1         Overview

9.1.1        Recent Developments by Players in Atrial Fibrillation Market

10.        Atrial Fibrillation Market- Key Company Profiles

10.1      Boston Scientific Corporation

10.1.1     1.1.1 Key Facts

10.1.2     Business Description

10.1.3     Products and Services

10.1.4     Financial Overview

10.1.5     SWOT Analysis

10.1.6     Key Developments

10.2      Medtronic

10.2.1     Key Facts

10.2.2     Business Description

10.2.3     Products and Services

10.2.4     Financial Overview

10.2.5     SWOT Analysis

10.2.6     Key Developments

10.3      AtriCure, Inc.

10.3.1     Key Facts

10.3.2     Business Description

10.3.3     Products and Services

10.3.4     Financial Overview

10.3.5     SWOT Analysis

10.3.6     Key Developments

10.4      Biosense Webster, Inc.

10.4.1     Key Facts

10.4.2     Business Description

10.4.3     Products and Services

10.4.4     Financial Overview

10.4.5     SWOT Analysis

10.4.6     Key Developments

10.5      BOEHRINGER INGELHEIM GMBH

10.5.1     Key Facts

10.5.2     Business Description

10.5.3     Products and Services

10.5.4     Financial Overview

10.5.5     SWOT Analysis

10.5.6     Key Developments

10.6      CardioFocus.

10.6.1     Key Facts

10.6.2     Business Description

10.6.3     Products and Services

10.6.4     Financial Overview

10.6.5     SWOT Analysis

10.6.6     Key Developments

10.7      Abbott

10.7.1     Key Facts

10.7.2     Business Description

10.7.3     Products and Services

10.7.4     Financial Overview

10.7.5     SWOT Analysis

10.7.6     Key Developments

10.8      Sanofi

10.8.1     Key Facts

10.8.2     Business Description

10.8.3     Products and Services

10.8.4     Financial Overview

10.8.5     SWOT Analysis

10.8.6     Key Developments

10.9      Bristol-Myers Squibb Company

10.9.1     Key Facts

10.9.2     Business Description

10.9.3     Products and Services

10.9.4     Financial Overview

10.9.5     SWOT Analysis

10.9.6     Key Developments

10.10   Biotronik, Inc.

10.10.1  Key Facts

10.10.2  Business Description

10.10.3  Products and Services

10.10.4  Financial Overview

10.10.5  SWOT Analysis

10.10.6  Key Developments

11.        Appendix

11.1      About The Insight Partners

11.2      Glossary of Terms

LIST OF TABLES

Table 1.             North America Atrial Fibrillation Market Revenue And Forecasts To 2027, By Product Type (US$ Mn)

Table 2.             North America Atrial Fibrillation Market Revenue And Forecasts To 2027, By Technology (US$ Mn)

Table 3.             North America Atrial Fibrillation Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 4.             North America Atrial Fibrillation market Revenue And Forecasts to 2027, By Product type (US$ Mn)

Table 5.             North America Atrial Fibrillation market Revenue And Forecasts to 2027, By technology (US$ Mn)

Table 6.             North America Atrial Fibrillation market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 7.             US Atrial Fibrillation market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

Table 8.             US Atrial Fibrillation market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 9.             US Atrial Fibrillation market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 10.          Canada Atrial Fibrillation market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

Table 11.          Canada Atrial Fibrillation market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 12.          Canada Atrial Fibrillation market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 13.          Mexico Atrial Fibrillation market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

Table 14.          Mexico Atrial Fibrillation market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 15.          Mexico Atrial Fibrillation market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 16.          Organic Developments Done By Companies

Table 17.          Inorganic developments done by Companies

Table 18.          Glossary Of Terms, Atrial Fibrillation Market

LIST OF FIGURES

Figure 1.           US Atrial Fibrillation Market, Revenue (US$ Mn), By Country 2018 & 2027

Figure 2.           North America Atrial Fibrillation Market By Product Type, Market Share (%), 2018

Figure 3.           North America Atrial Fibrillation Market By Technology, Market Share (%), 2018

Figure 4.           North America Atrial Fibrillation Market By End User, Market Share (%), 2018

Figure 5.           Atrial Fibrillation Market Segmentation

Figure 6.           North America PEST Analysis

Figure 7.           Atrial Fibrillation Market Impact Analysis Of Drivers & Restraints

Figure 8.           North America Atrial Fibrillation Market – Revenue Forecasts And Analysis – 2018- 2027

Figure 9.           North America Atrial Fibrillation Market, By Product Type, 2018 & 2027 (%)

Figure 10.        Implantable Atrial Fibrillation Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 11.        External Atrial Fibrillation Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 12.        North America Atrial Fibrillation Market By Technology, 2017 & 2025 (%)

Figure 13.        North America Single Chambered Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 14.        North America Dual Chambered Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 15.        North America Bi-Ventricular Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 16.        North America Atrial Fibrillation Market By End User, 2018 & 2027 (%)

Figure 17.        North America Hospitals Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 18.        North America Ambulatory Surgical Centers Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 19.        North America Others Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 20.        North America Atrial Fibrillation market revenue Overview, by Country (2017) (us $ mn)

Figure 21.        North America Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.        North America Atrial Fibrillation market Revenue And Forecasts to 2027, By Country (%)

Figure 23.        US Atrial Fibrillation market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24.        Canada Atrial Fibrillation market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.        Mexico Atrial Fibrillation market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26.        Comparative Company Analysis

Figure 27.        Growth Strategies Done by the Companies in the Market, (%)

 

The List of Companies - North America Atrial Fibrillation Market

 

  1. Boston Scientific Corporation
  2. Medtronic
  3. AtriCure, Inc
  4. BOEHRINGER INGELHEIM GMBH, Inc
  5. CardioFocus
  6. Abbott
  7. Sanofi
  8. Bristol-Myers Squibb Company
  9. Biotronik, Inc
  10. Biosense Webster, Inc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America Atrial Fibrillation market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the North America atrial fibrillation market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

 


Related Tags North America Atrial Fibrillation Market North America Atrial Fibrillation Market Research North America Atrial Fibrillation Market Insight North America Atrial Fibrillation Market Trends North America Atrial Fibrillation Market Forecast North America Atrial Fibrillation Market Share North America Atrial Fibrillation Market 2027 North America Atrial Fibrillation Market Growth North America Atrial Fibrillation Industry Sector North America Atrial Fibrillation PDF Report North America Atrial Fibrillation Analysis North America Atrial Fibrillation Research Competitive Analysis

Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000